Stay updated with breaking news from First Participant. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Issuer: CureVac / Key word: Study CureVac Announces Dosing of First Participant in a Phase 2 Study in Seasonal Influenza; Development in Collaboration with GSK...
Issuer: CureVac / Key word(s): Study28.05.2024 / 13:00 CET/CESTThe issuer is solely responsible for the content of this announcement.CureVac Announces Dosing of First Participant in a Phase 2 Study in Seasonal Influenza; Development in Collaboration with GSK Phase 2 study to assess updated formulations for im...
Issuer: CureVac / Key word(s): Study08.05.2023 / 13:00 CET/CESTThe issuer is solely responsible for the content of this announcement.CureVac Announces Dosing of First Participant in Combined Phase 1/2 Study of Multivalent, Modified Influenza Vaccine Candidates Developed in Collaboration with GSK Initial Phase...